Nurix Other Non Cash Items from 2010 to 2024

NRIX Stock  USD 19.11  0.82  4.11%   
Nurix Therapeutics Other Non Cash Items yearly trend continues to be fairly stable with very little volatility. Other Non Cash Items is likely to outpace its year average in 2024. During the period from 2010 to 2024, Nurix Therapeutics Other Non Cash Items regression line of annual values had r-squared of  0.32 and arithmetic mean of (721,138). View All Fundamentals
 
Other Non Cash Items  
First Reported
2019-08-31
Previous Quarter
17.4 M
Current Value
-3.4 M
Quarterly Volatility
4.4 M
 
Covid
Check Nurix Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nurix Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 13.4 M or Interest Income of 13.4 M, as well as many indicators such as Price To Sales Ratio of 4.8, Dividend Yield of 0.0 or PTB Ratio of 1.59. Nurix financial statements analysis is a perfect complement when working with Nurix Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Nurix Therapeutics Correlation against competitors.
For more information on how to buy Nurix Stock please use our How to Invest in Nurix Therapeutics guide.

Latest Nurix Therapeutics' Other Non Cash Items Growth Pattern

Below is the plot of the Other Non Cash Items of Nurix Therapeutics over the last few years. It is Nurix Therapeutics' Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nurix Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Other Non Cash Items10 Years Trend
Slightly volatile
   Other Non Cash Items   
       Timeline  

Nurix Other Non Cash Items Regression Statistics

Arithmetic Mean(721,138)
Geometric Mean70,395
Coefficient Of Variation(277.82)
Mean Deviation1,498,621
Median(6,000)
Standard Deviation2,003,491
Sample Variance4T
Range6.7M
R-Value(0.57)
Mean Square Error2.9T
R-Squared0.32
Significance0.03
Slope(253,793)
Total Sum of Squares56.2T

Nurix Other Non Cash Items History

2024-4.2 M
2023-4.4 M
2022-4.9 M
2021636 K
20201.8 M
2019273 K
2018-109 K

About Nurix Therapeutics Financial Statements

Nurix Therapeutics investors use historical fundamental indicators, such as Nurix Therapeutics' Other Non Cash Items, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nurix Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Non Cash Items-4.4 M-4.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Nurix Stock Analysis

When running Nurix Therapeutics' price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.